-- Scott Roberts
TUESDAY, Jan. 25 (HealthDay News) -- Sanofi-Aventis'
prescription non-drowsy antihistamine, Allegra (fexofenadine), has
been approved by the U.S. Food and Drug Administration for
over-the-counter sale, the company said Tuesday.
The drug will be available in its original prescription
strengths starting in March for people two years and older,
according to a news release from Sanofi and its U.S. consumer
division, Chattem Inc. A version that combines Allegra with a
decongestant, Allegra-D, will be available at the same time for
people 12 and older without a prescription at the pharmacy counter,
the companies said.
More than 40 million Americans have indoor or outdoor allergies,
the drug makers said.
To learn more about this drug, visit the U.S.
National Library of Medicine.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.